Observational Study on Contraception With Essure in France
NCT ID: NCT02510443
Last Updated: 2017-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2644 participants
OBSERVATIONAL
2008-06-23
2016-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01861886
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01948882
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
NCT03623126
Improvement of Symptoms After Removal of the Essure® Contraceptive Implant
NCT06355713
Essure Permanent Birth Control, Effectiveness and Safety: A French Survey
NCT03955822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BAY1454032
All subjects who give their consent and meet the eligibility criteria will be scheduled for an insert placement procedure
ESS305 (Essure, BAY1454032)
Bilateral insert placement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ESS305 (Essure, BAY1454032)
Bilateral insert placement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for Essure procedure
* Patient who has been given appropriate information about the study objectives and procedures and who has given her consent.
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital André Mignot Centre Hospitalier de Versailles
UNKNOWN
Bayer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bayer Study Director
Role: STUDY_DIRECTOR
Bayer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Le Chesnay, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ES0810FR
Identifier Type: OTHER
Identifier Source: secondary_id
18097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.